MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/10781552261443919

Медицинская библиотека · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2026

Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia.

Jang Jeffrey, Nold Timothy, Marshalek Joseph P, Matthiesen Jessica, Tomassetti Sarah

СтатьяПеревод пока не подготовлен

Аннотация

Introduction

Patients with acute myeloid leukemia (AML) are immunocompromised as a result of their malignancy and treatment, which can predispose to infection. The incidence of bacterial infection is most common (75-80%), followed by fungal (7-33%) and viral (12-20%) infections. Prophylaxis is recommended; however, uncertainty exists regarding optimal agent and duration.

Methods

We present a single-center retrospective experience of 63 patients with AML from 2014-2024 investigating prophylaxis, infections, risk factors, and survival.

Results

Median age was 53 years old, and the most common induction therapies were 7 + 3 (63%), azacitidine (11%), azacitidine + venetoclax (6%), and 7 + 3 + midostaurin (6%). Prophylaxis against fungal, viral, and bacterial infections was used in 87%, 75%, and 11% of patients. Across all lines of therapy, fungal, viral, and bacterial infections were diagnosed in 22%, 19%, and 78% of patients. Antiviral prophylaxis was associated with a statistically significant reduction in viral infections (13% vs. 38%, p = 0.029) with no significant impact on overall survival (HR 0.85, 95% CI 0.32-2.26, p = 0.731). Antifungal and antibacterial prophylaxis were not associated with a decreased risk of infection nor improved survival. The rate of fungal infection was higher in patients with adverse risk AML compared to intermediate or favorable risk (41% vs. 15%, p = 0.028).

Conclusion

This study provides valuable insight regarding prophylaxis and infections in AML patients, demonstrating the benefit of antiviral prophylaxis in reducing viral infections and the substantial risk of bacterial infection throughout all phases of treatment.

Для цитирования: Jang Jeffrey, Nold Timothy, Marshalek Joseph P, Matthiesen Jessica, Tomassetti Sarah. Retrospective study of antimicrobial prophylaxis and infections in patients with acute myeloid leukemia.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2026. DOI: 10.1177/10781552261443919.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.